NCT05697250

Brief Summary

The primary aim of the study is to compare the operative times following ureteroscopic lithotripsy for renal stones with Thulium Fiber Laser using low and high power settings. Secondary aims are to compare the results of low and high power settings in terms of stone free rates, laser time, laser activation patterns, intraoperative and postoperative complications. Patients ≥ 18 years with renal stones (8-25 mm) scheduled for ureteroscopic lithotripsy at the Day Surgery Clinic at Haukeland University Hospital in Bergen, Norway, are eligible for inclusion in the study. After written consent and inclusion, patients are randomised to laser lithotripsy using either low power settings (Group 1: 4-6 Watt, short pulse mode) or high power settings (Group 2: 16-18 Watt, short pulse mode). The ureteroscopic procedures are performed in general anaesthesia using a standardised technique. All patients are followed up with a low dose CT scan 3 months post endoscopically to assess stone free status as well as a consultation at the outpatient clinic. Results and data for the two randomisation groups are compared according to the aims of the study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2022

Completed
25 days until next milestone

Study Start

First participant enrolled

January 23, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 25, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

March 5, 2025

Status Verified

March 1, 2025

Enrollment Period

2.7 years

First QC Date

December 29, 2022

Last Update Submit

March 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Operative time

    Surgical time in minutes, counted from start of the procedure with insertion of the cystoscope until emptying the bladder in the end.

    During surgery (approximately 1 hour), registered immediately after surgery

Secondary Outcomes (5)

  • Stone free rate

    3 months post endoscopically

  • Laser activation patterns - duration

    During surgery (approximately 1 hour), registered immediately after surgery

  • Laser activation patterns - number

    During surgery (approximately 1 hour), registered immediately after surgery

  • Intraoperative complications

    During surgery (approximately 1 hour), registered immediately after surgery

  • Post operative complications

    After surgery until 3 months post endoscopically.

Study Arms (2)

Group 1 - low power laser settings

EXPERIMENTAL

4-6 Watts, short pulse mode. 0.4 - 0.6 J at 10 Hz.

Other: Laser power settings (Thulium Fiber Laser)

Group 2 - high power laser settings

EXPERIMENTAL

16-18 Watts, short pulse mode. 0.4 J / 40 Hz, 0.6 J / 30 Hz or 0.8 J / 20 Hz.

Other: Laser power settings (Thulium Fiber Laser)

Interventions

Ureteroscopic lithotripsy using low power laser settings (0.4 - 0.6 J at 10 Hz corresponding to 2.4 - 6.0 Watts) or high power laser settings (0.4 J at 40 Hz, 0.6 J at 30 Hz or 0.8 J at 20 Hz corresponding to 16 - 18 Watts).

Group 1 - low power laser settingsGroup 2 - high power laser settings

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital

You may not qualify if:

  • Concomitant ureteral stone
  • Urinary diversion
  • Active infection
  • Untreated cancer in the upper urinary tract

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland University Hospital

Bergen, Vestland, 5021, Norway

RECRUITING

MeSH Terms

Conditions

Nephrolithiasis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Study Officials

  • Øyvind Ulvik, Assoc Prof

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Øyvind Ulvik, Assoc Prof

CONTACT

Mathias S Æsøy, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Stone free status is assessed on low dose CT 3 months post endoscopically by an outcome assessor blinded to the randomisation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The patients are randomised to ureteroscopic stone treatment with Thulium Fiber Laser with either low or high laser settings. The ureteroscopic procedures are performed in a standardised manner irrespective of the laser settings, and follow-up is similar in both groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2022

First Posted

January 25, 2023

Study Start

January 23, 2023

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

March 5, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations